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Protein quantitative trait locus study in obesity
during weight-loss identiﬁes a leptin regulator
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Thousands of genetic variants have been associated with complex traits through genome-
wide association studies. However, the functional variants or mechanistic consequences
remain elusive. Intermediate traits such as gene expression or protein levels are good proxies
of the metabolic state of an organism. Proteome analysis especially can provide new insights
into the molecular mechanisms of complex traits like obesity. The role of genetic variation in
determining protein level variation has not been assessed in obesity. To address this, we
design a large-scale protein quantitative trait locus (pQTL) analysis based on a set of 1129
proteins from 494 obese subjects before and after a weight loss intervention. This reveals
55 BMI-associated cis-pQTLs and trans-pQTLs at baseline and 3 trans-pQTLs after the
intervention. We provide evidence for distinct genetic mechanisms regulating BMI-associated
proteins before and after weight loss. Finally, by functional analysis, we identify and validate
FAM46A as a trans regulator for leptin.
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Thousands of genetic variants have been associated withcomplex traits or diseases through genome-wide associa-tion studies (GWAS)1. However, the mechanisms of action
by which they inﬂuence traits or diseases are often unclear since
most of these variants are not functional, generally located in
intergenic regions or surrounding genes of unknown function.
Recently, the largest GWAS meta-analysis of body mass index
(BMI) performed in 339,224 individuals identiﬁed 97 BMI-
associated2 common variants. However, all of these studies have
been performed at the population level apart from a few candi-
date gene studies conducted in obese individuals during a weight
loss intervention3,4. Availability of high-throughput omics tech-
nologies like proteomics and transcriptomics combined with
genetic variants may provide new insights into the genetic
mechanisms of complex traits. A large number of expression
quantitative trait (eQTL) analyses investigated the role of com-
mon genetic variants on gene expression in complex traits
yielding a better understanding of their underlying mechanism5.
Proteins as the main working blocks of metabolism are good
proxies of the metabolic state of an organism. Likewise, changes
of protein levels during interventions can provide insights into
the level of response and sometimes predict long-term outcomes6.
Thus, proteome analysis holds the promise to provide new
insights into the understanding of mechanisms underlying dis-
eases. This is especially true for metabolic diseases including
obesity7. Indeed, proteomics has already provided some promis-
ing results for the understanding of molecular mechanisms and
pathogenesis of obesity and related traits6,8,9. These studies have
shown that the levels of many proteins vary signiﬁcantly between
obese and normal weight individuals. More importantly, many
proteins have been shown to be differentially expressed in plasma
of obese individuals before and after a weight loss intervention6.
Weight loss and maintenance are hallmarks of treating obesity
and in the prevention of obesity related co-morbidities like type 2
diabetes and cardiovascular disease10,11. However, the capacity to
lose weight and keep the lost weight off is highly variable among
individuals and so are their protein proﬁles6.
The role of genetic variation in determining protein level
variation has not been assessed in obesity. Until recently pQTL
analyses were limited to modest sets of proteins in cohorts of
moderate size but recent access to high-throughput technologies
present the opportunity to perform large genome-wide pQTL
analyses. To date only few large-scale pQTL studies have been
reported and only two of them performed in mice and Drosophila
investigated protein changes under different intervention
conditions12,13.
To investigate how genetic variation affects protein levels both
at baseline and during a low-calorie-induced weight loss, we
designed a pQTL analysis based on a set of 1129 proteins avail-
able from 494 obese participants from the DIOGenes (DIet,
Obesity, and Genes) intervention trial14. We used additional
information from transcriptomics available for a subset of 151
participants to perform local eQTL analyses in an effort to
identify the causal mediator of distant trans-pQTL’s. This study
identiﬁes genetic factors contributing to the variation of protein
levels in a complex trait on a large-scale. The results of the
integration of different omics data provide evidence for distinct
genetic mechanism regulating BMI-associated proteins before
and after a dietary-weight loss intervention.
Results
Proteome-wide association study. At baseline, 192 proteins were
signiﬁcantly associated with BMI (Fig. 1a and Supplementary
Data 1) with the majority (n = 117) showing negative correlations
(i.e., low protein expression associated to high BMI). Leptin,
widely investigated in obesity15, displayed the strongest associa-
tion with BMI at baseline. Other proteins previously linked to
obesity or related traits included CRP16, IGFBP-117, kalistatin18,
factor H19, or antithrombin III20. Proteins associated with BMI
for the ﬁrst time in our study included UNC5F4, a receptor for
netrin involved in cell migration and angiogenesis21. Netrin-1
likely plays a key role in the retention of macrophages in the
visceral white adipose tissue in obesity, promoting insulin resis-
tance, and chronic inﬂammation22.
Changes of BMI during the 8 week low-calorie dietary
(LCD) weight loss were associated with a variation in the
levels of 104 proteins (Fig. 1b and Supplementary Data 2), of
which 51 showed negative correlations and 53 positive correla-
tions with degree of weight loss respectively. Proteins associated
with weight loss known to be involved in obesity or related traits
included leptin15, growth hormone receptor23, TIG224
(chemerin), insulin-like growth factor-binding protein-2
(IGFBP2)25 or sex hormone-binding globulin26 (SHBG). Proteins
we identiﬁed as potentially linked to obesity for the ﬁrst time
included the RET proto-oncogene (granulysin). Granulysin is
present in cytotoxic granules of T lymphocytes and natural killer
cells. Lynch et al.27 observed decreased circulating natural killer
and cytotoxic T lymphocytes in obese patients compared to lean
controls.
Forty-two proteins were associated both with BMI at baseline
and after the LCD intervention, respectively, a signiﬁcant excess
of shared proteins for the two time periods (hypergeometric test’s
p = 1.9 × 10−9). Leptin displayed the strongest association with
BMI, both at baseline and during the intervention (Fig. 1c).
Insulin-like growth factor-binding protein 1 (IGFBP-1),
UNC5H4 or antithrombin III displayed stronger association with
BMI at baseline than during the intervention whereas an inverse
tendency was observed for IGFBP2 or SHBG. Recently, a
proteome-wide study tested the association between BMI and
3,620 plasma proteins in 3,301 healthy individuals from the
general population using the SOMAscan technology28. In this
external study, summary statistics were available for 38 of our 42
BMI-associated proteins (Supplementary Table 1). All of our 38
proteins demonstrated signiﬁcant association with BMI (with
Bonferroni corrected p value< 0.05) in this large data set.
Association with BMI was in the same direction for all but two
proteins, angiopoietin-2 and GDF-11.
Functional networks for obese-speciﬁc proteins during LCD.
Correlation heatmaps for the 42 proteins associated with BMI at
baseline and BMI change during LCD displayed similar patterns
before and during the intervention. However, correlations were
generally strongest during the intervention (Fig. 2).
Canonical pathway analysis identiﬁed the coagulation
system as modulated by this subset of 42 protein-coding genes
(p = 2.53 × 10−4 and corrected p = 0.049). Ingenuity pathway
analysis (IPA) identiﬁed three major networks of interacting
proteins. The largest network (Supplementary Fig. 1a) included
20 proteins and was predicted to be involved in tissue
morphology, inﬂammatory response and cardiovascular diseases
including proteins encoded by genes already associated with
obesity (INS, LEP, SERPINE1, IL1RAP, and RARRES2). The
second network (n = 10 proteins) was connected to organismal
injury and abnormalities, and cellular and embryonic develop-
ment (Supplementary Fig. 1b), the third network (n = 7 proteins)
to developmental disorders, endocrine system disorders, heredi-
tary disorders (Supplementary Fig. 1c).
pQTL association results at baseline. GWAS pQTL analysis of
192 BMI-associated proteins at baseline identiﬁed 57 pQTL’s: 34
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(Table 1) and 22 (Table 2) with expression associated with 102
cis-pQTL SNPs and 45 trans-pQTL SNPs, respectively. Adding
BMI as a confounder in the analysis did not affect these results
(Tables 1 and 2). The majority of SNPs were located within
intronic (31%) or intergenic (50%) regions in similar proportion
between cis-acting and trans-acting SNPs (Table 3). Cis-acting
pQTLs were signiﬁcantly enriched in variants in 5′ upstream
(p = 6.1 × 10−4) and coding (p = 2.2 × 10−4) regions.
The strongest cis-pQTL association signals were located in the
interleukin proteins IL-1R AcP (rs6444442, p = 4.6 × 10−66) and
IL-16 (rs4778636, p = 1.0 × 10−35; Table 1) and the apolipoprotein
SAA (rs7950019, p = 4.8 × 10−45). As expected, trans-pQTL
association signals were generally weaker than cis-pQTLs
(Table 2) but were still highly signiﬁcant for sE-Selectin protein
levels that have been linked to obesity29. The most signiﬁcant
trans-pQTL SNP for sE-Selectin (rs495828, p = 9.0 × 10−40;
Supplementary Fig. 2a) was located within the ABO gene. This
SNP was in complete linkage disequilibrium (pairwise linkage
disequilibrium (LD) r2 = 1.00) with rs651007, already associated
with variation of sE-Selectin levels in two large Caucasian
cohorts30. We also observed a nominally signiﬁcant eQTL
association within the same region of the ABO gene (Supple-
mentary Fig. 2b) at baseline (eQTL association signal for
rs630510, p = 3.0 × 10−4 in moderate LD r2 = 0.27 with rs495828
pQTL SNP). Based on the GTEx database, sE-Selectin trans-
pQTL SNP rs495828 was associated with the expression of ABO
gene in visceral and subcutaneous adipose tissues. Among others,
an interesting trans-pQTL is for calpastatin on chromosome 10.
Calpastatin is an endogenous calpain inhibitor and is involved in
inﬂammatory processes31. The strongest trans-pQTL for this
protein lies in the carboxypeptidase N subunit 1 (CPN1) gene.
Transcriptomics data were not available for CPN1. However, we
detected a cis-eQTL association between the most signiﬁcant
pQTL SNP, rs11599750 (Table 2), and gene expression at baseline
(p = 9.9 × 10−4) for the CWF19L1 gene. This gene is located
150Kb downstream from CPN1 (Supplementary Fig. 3).
At baseline, we identiﬁed pQTLs acting on the levels of
multiple proteins. One locus on chromosome 3 was signiﬁcantly
associated with the levels of 3 distinct proteins (Supplementary
Fig. 4a–c): PUR8 encoded by the ADSL gene; ferritin encoded by
FTH1 and ﬁnally CA1, a carbonic anhydrase (CA). Baseline
expression levels were signiﬁcantly correlated between all three
proteins (Spearman correlation test with p< 1.0 × 10−6 and
Spearman ρ> 0.4 for all pairwise correlations). The pQTL region
included the gene for KCNAB1, a regulator of insulin secretion,
neurotransmitter release and smooth muscle contraction, and the
TIPARP gene, which encodes a poly (ADP-ribose) polymerase
involved in DNA repair. Results from our eQTL analysis for all
genes in the region identiﬁed TIPARP as the gene with the
strongest association signal (Supplementary Fig. 4d). This gene
was identiﬁed in a genome-wide meta-analysis as a potential
candidate for the regulation of circulating leptin levels and its
expression was increased in subcutaneous adipose tissue and liver
of mice fed with a high-fat diet32.
Two studies recently published genome-wide pQTL studies
in population-based cohorts28,33. The study by Suhre et al.33,
analyzed the population-based KORA (Cooperative Health
Research in the Region of Augsburg) for discovery and the Qatar
Fig. 1 Association analysis between proteins expression and BMI.
a Volcano plots for 192 proteins with expression associated to BMI at
baseline and b 104 proteins for which change in expression level was
associated to BMI change during LCD intervention. x-axis represents the
effect size from the association test and y-axis the corresponding –log10 p
value from a linear regression adjusted for age, gender, and center. p value
were colored in red for proteins with signiﬁcant association. A positive
effect characterizes a protein expression decrease with weight loss while a
negative effect depicts an increase of protein expression with weight
loss during LCD intervention. Proteins with strong association to BMI
change (p value< 1.0 × 10−6) are named. c p values from association
tests for 42 proteins associated at baseline and during LCD. Each dot
corresponds to a protein with –log10 p value association test at baseline
(x-axis) and during LCD (y-axis)
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Fig. 2 Proteins correlation heatmaps. Correlation for 42 proteins whose expression was associated to BMI at both time periods. Pairwise Spearman
correlation between proteins computed using (a) expression level residuals at baseline and (b) expression fold change residuals during LCD intervention.
Residuals were computed regressing proteins level at baseline or proteins expression fold change during LCD on confounding cofactors (age, gender,
and center)
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Metabolomics Study on Diabetes (QMDiab) for replication. Eight
of our pQTL SNPs were signiﬁcant in KORA and four of them
successfully replicated in QMDiab. We also compared our results
with the study by Sun et al.28. This highlighted two additional
pQTLs (Supplementary Data 3).
Since these comparisons were limited to the presence of the
same SNP marker, we extended it to a locus-based comparison
(i.e. QTL signals). This was done by extending association signals
to pQTL SNPs and SNPs in moderate LD (r2> 0.2 based on 1000
Genomes Project genotype European reference population). This
approach showed that 39 and 34 of our QTL signals were in
common with those reported by Suhre et al.33 or Sun et al.28
respectively. Speciﬁcally, 22 QTL signals were shared between all
three studies (Supplementary Data 4). pQTL signals, we
replicated included IL-1R AcP described above and CA6,
discussed later in this paper.
pQTL associations under a low-calorie diet challenge. Changes
in 104 proteins were associated with BMI variation during the
LCD intervention. Our pQTL analysis identiﬁed three proteins
signiﬁcantly regulated by four SNPs. All were trans-acting
pQTLs (Table 4) and intergenic except rs1544241, located in the
5′-upstream region of the pseudogene RP11-672L10.5. Inclusion
of BMI as a confounder in the statistical model did not impact
association results (Table 4).
One SNP located in a large intergenic region on chromosome
6 displayed the strongest pQTL association signal. This
SNP, rs13200531, was associated with angiotensinogen protein
level changes (p = 3.88 × 10−10). Expressed in adipose tissue,
angiotensinogen contributes to diet-induced obesity34. In our
DIOGenes eQTL study, the SNP did not display association
signals with any gene in the region. SNP rs1544241 was identiﬁed
as a trans-acting pQTL for caspase-10 a protein involved in
apoptosis reported in adipocytes of obese subjects35. eQTL
association results from genes surrounding the locus did not
highlight any potential regulatory gene. Two SNPs were
associated with changes in leptin levels during the LCD as
detailed below. During LCD intervention, leptin was correlated
with caspase-10 (Spearman ρ = 0.12 and p = 9 × 10−3) and
angiotensinogen (Spearman ρ = 0.23 and p = 1.55 × 10−7). Leptin
is known to inhibit apoptosis via downregulation of caspase-1036
and was found signiﬁcantly correlated with plasma angiotensino-
gen in healthy normotensive subjects37.
pQTL effects on CA6, chemerin, and leptin protein expression.
Of the 192 proteins associated with BMI at baseline, 42
also showed signiﬁcant association during LCD. In total, 14
(Supplementary Data 5) of these 42 displayed signiﬁcant pQTL
signals at baseline but not after the LCD. Nonetheless, we con-
sidered that two of them, CA6 (gustin) and chemerin, deserved
further investigation because of the biological relevance to
Table 1 Cis-acting SNP association results for 34 proteins with signiﬁcant pQTL signal at baseline
PROTEIN SNP Chr Position MA MAF Coef SE p value Adjusted p value
IL-1 R AcP rs6444444 3 190346231 A 0.16 0.66 0.039 4.60 × 10−66 1.05 × 10−69
SAA rs7950019 11 18278912 G 0.37 1.53 0.109 4.81 × 10−45 2.52 × 10−44
IL-16 rs4778636 15 81591639 A 0.07 −0.48 0.039 1.00 × 10−35 7.68 × 10−37
MIA rs2607426 19 41274713 G 0.06 0.49 0.04 3.95 × 10−34 8.55 × 10−36
HCC-4 rs11080369 17 34305164 C 0.05 −0.79 0.069 1.58 × 10−30 6.97 × 10−31
kallikrein 12 rs3745540 19 51535130 A 0.38 0.33 0.029 8.36 × 10−29 4.54 × 10−28
sICAM-5 rs281440 19 10400304 G 0.24 −0.3 0.028 6.75 × 10−27 1.95 × 10−27
NPS-PLA2 rs10732279 1 20305065 C 0.27 0.38 0.036 3.44 × 10−26 5.76 × 10−27
ATS13 rs4962144 9 136275141 A 0.1 −0.34 0.035 7.08 × 10−23 1.84 × 10−22
ECM1 rs13294 1 150484987 A 0.44 −0.2 0.02 6.65 × 10−22 4.38 × 10−22
PARC rs972317 17 34371659 G 0.12 0.5 0.052 6.90 × 10−22 4.61 × 10−23
Carbonic anhydrase 6 rs3765964 1 9034421 A 0.39 0.44 0.052 3.37 × 10−17 3.20 × 10−17
Factor H rs1329428 1 196702810 T 0.43 0.08 0.009 4.94 × 10−16 1.22 × 10−16
TECK rs11671930 19 8117308 C 0.16 −0.5 0.063 1.38 × 10−15 1.23 × 10−15
Haptoglobin mixed
type
rs2000999 16 72108093 A 0.2 −0.49 0.062 3.23 × 10−15 2.56 × 10−16
FCN2 rs7851696 9 137779091 T 0.11 −0.38 0.049 4.61 × 10−15 1.07 × 10−15
Kallistatin rs5510 14 95033356 T 0.24 0.11 0.014 8.78 × 10−14 2.27 × 10−15
Cripto rs3806702 3 46617502 C 0.27 0.14 0.019 9.53 × 10−14 2.57 × 10−13
CYTN rs6036507 20 23721992 A 0.3 0.31 0.042 2.25 × 10−13 2.04 × 10−13
WFKN2 rs4586493 17 48924465 A 0.28 0.18 0.026 7.84 × 10−12 3.25 × 10−12
CYTT rs6036507 20 23721992 A 0.3 0.3 0.045 1.02 × 10−11 2.04 × 10−13
Contactin-5 rs1461674 11 99180043 T 0.08 0.23 0.035 1.18 × 10−11 3.21 × 10−12
MIP-1a rs972317 17 34371659 G 0.12 0.35 0.051 1.33 × 10−11 4.61 × 10−23
Factor B rs541862 6 31916951 C 0.08 0.15 0.023 3.39 × 10−11 6.73 × 10−12
Proteinase-3 rs2074639 19 840984 T 0.22 0.22 0.033 5.74 × 10−11 1.39 × 10−10
TIG2 rs10282458 7 150045302 A 0.25 0.12 0.018 2.11 × 10−10 1.34 × 10−9
LD78-beta rs972317 17 34371659 G 0.12 0.2 0.032 3.27 × 10−10 4.61 × 10−23
TSG-6 rs6715902 2 152201469 A 0.34 0.18 0.031 3.23 × 10−9 8.92 × 10−9
LBP rs2284878 20 36785127 A 0.06 −0.36 0.062 4.07 × 10−9 5.92 × 10−9
C7 rs3805221 5 40965318 T 0.24 −0.12 0.02 6.73 × 10−9 7.45 × 10−9
Factor I rs7439493 4 110656730 A 0.42 0.06 0.01 1.46 × 10−8 4.69 × 10−9
Kallikrein 7 rs1654523 19 51485194 C 0.08 −0.24 0.044 5.57 × 10−8 1.75 × 10−8
TSP2 rs3763267 6 169571693 C 0.09 0.29 0.053 5.66 × 10−8 5.20 × 10−8
CHL1 rs6769747 3 244949 G 0.1 0.16 0.03 1.37 × 10−7 6.81 × 10−6
pQTL association results are provided with (adjusted p value) and without (p value) adjusting for BMI
SNP single-nucleotide polymorphism, Chr chromosome, MA minor allele, MAF minor allele frequency, Coef estimated association coefﬁcient, SE standard error
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obesity and strong, consistent genetic association signals during
the LCD.
The ﬁrst protein, CA6 (gustin), was signiﬁcantly regulated
by proximal common variants at baseline (rs3765964,
p = 3.37 × 10–17; Supplementary Fig. 5). Gustin controls the
salivary trophic factor and a disruption in the protein
decreases taste function. Gustin is a zinc-dependent enzyme.
Genetic variants in gustin are associated with individual ability to
taste 6-n-propylthiouracil (PROP) which in turn is inversely
related to BMI and salivary ionic zinc concentrations38. The
PROP phenotype has been associated with variation in the
perception and preference for fat39, energy intake, and body
weight40,41. The strongest pQTL signal for the protein during
LCD (Supplementary Fig. 6) was in trans and located in the
promoter region of OR2W5, an olfactory receptor in the nose.
This SNP (rs7512601; Supplementary Fig. 7) displayed strong
association with gustin protein levels (p = 3.8 × 10−7; Supplemen-
tary Fig. 8) but did not reach signiﬁcance after multiple testing
correction (pcorrected = 0.10). None of the pQTL SNPs showed an
eQTLs signal for other genes in a 5Mb surrounding region in our
data.
The second protein, chemerin, was signiﬁcantly regulated at
baseline by cis-acting SNPs with the strongest signal for
rs10282458 (p = 2.11 × 10−10, Supplementary Fig. 5). Changes
in protein levels during LCD displayed its strongest association
with rs11113832 (pnominal = 1.5 × 10−6; pcorrected = 0.37; Supple-
mentary Fig. 9), a trans-pQTL SNP located in the promoter
region of the chemerin receptor gene CMKLR1. Adding
information from imputed SNPs, the region shows enrichment
of an association signal (Supplementary Fig. 10). Our transcrip-
tomics data did not identify cis-eQTLs for CMKLR1 gene
expression. Chemerin plays an important role in obesity as an
adipokine involved in the regulation of adipogenesis and
adipocyte metabolism42.
Among the 42 proteins associated with BMI both at baseline
and during the LCD, only leptin displayed a signiﬁcant pQTL
signal during LCD. Two tightly linked SNPs in an intergenic
region on chromosome 6 were associated with leptin protein
expression changes (Fig. 3 and Supplementary Fig. 7). Surround-
ing genes included BCKDHB, involved in the catabolism of
branched chain amino acids (BCAAs); and FAM46A, a SMAD
signaling pathway related protein involved in TGF-β signaling
pathway43. Using adipocyte expression data from our study we
performed an eQTL analysis. Only the FAM46A gene expression
displayed association with SNPs in the pQTL region. No other
gene within 5Mb around the pQTL locus displayed eQTL
association signals higher than the FAM46A signal in our data.
The biological role of FAM46A is largely unknown. The protein
interacts with the BAG6 protein44 involved in gene regulation,
apoptosis, regulation of protein synthesis, and degradation. It has
recently been shown that BAG6 splicing in subcutaneous fat is
highly determined by BMI45. BAG6 is also involved in stress
response. There is a reciprocal relationship between heat shock
protein HSP70 and BAG6 suggesting that BAG6 could be a
central regulator of the cellular content of HSP7046 which is in
turn positively associated with leptin in type 2 diabetes47 and in
our data (p = 3.4 × 10−4 from a multivariate regression adjusted
for age, gender, center, and BMI change during LCD interven-
tion). pQTL association signals in the regulatory region of
FAM46A were also observed for HSP70 (Supplementary Fig. 11a).
Adjusting for leptin expression change as a confounding cofactor
did not affect pQTL results (Supplementary Fig. 11b). In other
words, the HSP70 pQTL signal in the FAM46A regulatory region
was leptin-level independent.
The reciprocal relationship between FAM46A and leptin is also
apparent during adipocyte maturation. In preadipocytes FAM46A
expression is high and decreases during maturation to a
minimum at day seven. This decrease coincides with the
appearance of leptin (Supplementary Fig. 12). To complete the
genetic characterization of the QTL results we evaluated the
directionality of pQTL and eQTL SNPs. We ﬁrst focused on the 2
pQTL SNPs signiﬁcantly associated with leptin change during
LCD. SNP rs9344031 was positively associated with leptin protein
level change (p = 1.48 × 10−7) and negatively associated with
FAM46A gene expression change (p = 4.9 × 10−3). The same trend
was found for the second pQTL SNP rs481777 although gene
Table 2 Trans-acting SNP association results for 22 proteins with signiﬁcant pQTL signal at baseline
Protein SNP Chr Position MA MAF Coef SE p value Adjusted p value
sE-Selectin rs495828 9 136154867 T 0.2 −0.5 0.04 8.98 × 10−40 1.13 × 10−39
Calpastatin rs11599750 10 101805442 T 0.4 −0.2 0.02 3.78 × 10−12 2.49 × 10−12
FCN2 rs7103402 11 114391633 T 0.1 −0.3 0.05 7.27 × 10−11 1.69 × 10−10
MP2K2 rs12876365 13 113911651 T 0.2 −0.2 0.03 3.37 × 10−10 1.27 × 10−10
HAI-1 rs1886748 1 39333775 A 0.4 −0.2 0.03 6.97 × 10−10 5.62 × 10−10
IDS rs7661253 4 183039092 C 0.4 −0.2 0.03 1.50 × 10−9 3.68 × 10−9
CATZ rs10860794 12 102217720 A 0.3 −0.1 0.02 1.78 × 10−9 7.39 × 10−9
40 S ribosomal protein SA rs7299019 12 105271085 T 0.1 0.27 0.05 1.56 × 10−8 7.98 × 10−9
PUR8 rs10513494 3 156291263 G 0.1 0.42 0.08 2.74 × 10−8 6.52 × 10−8
a1-Antichymotrypsin rs10509957 10 114053983 A 0.4 −0.1 0.01 3.80 × 10−8 2.46 × 10−7
Carbonic anhydrase I rs10513494 3 156291263 G 0.1 0.42 0.08 3.93 × 10−8 1.13 × 10−7
TGF-b3 rs2058950 7 155182326 A 0.2 0.1 0.02 7.13 × 10−8 1.05 × 10−7
IL-7 rs7836269 8 13748948 G 0.1 0.31 0.06 7.66 × 10−8 1.90 × 10−7
Cytochrome c rs9325542 10 114977369 G 0.2 0.15 0.03 7.86 × 10−8 2.45 × 10−7
ACTH rs2268992 6 88183647 G 0.1 0.35 0.07 9.18 × 10−8 2.27 × 10−8
MMP-16 rs11230085 11 59578322 A 0.1 0.23 0.04 9.68 × 10−8 1.25 × 10−7
Nectin-like protein 1 rs12420752 11 21866461 T 0.1 0.31 0.06 1.18 × 10−7 2.27 × 10−7
BGN rs7309378 12 12828528 A 0.1 −0.2 0.04 1.24 × 10−7 7.15 × 10−7
Coactosin-like protein rs10908893 9 92117102 T 0 0.32 0.06 1.27 × 10−7 2.53 × 10−8
NKp44 rs1432180 2 82079857 A 0.2 0.11 0.02 1.51 × 10−7 2.67 × 10−7
MMP-2 rs7935013 11 467339 G 0.3 0.09 0.02 1.52 × 10−7 8.29 × 10−7
Ferritin rs12485954 3 156336114 C 0.1 0.47 0.09 1.54 × 10−7 3.40 × 10−7
pQTL association results are provided with (adjusted p value) and without (p value) adjusting for BMI
SNP single-nucleotide polymorphism, Chr chromosome, MA minor allele, MAF minor allele frequency, Coef estimated association coefﬁcient, SE standard error
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expression did not reach nominal signiﬁcance (p = 0.12) likely
because of the difference in sample size between the eQTL and
pQTL study. In an enlarged analysis, pQTL signals were extracted
in the promoter region of FAM46A located between 81.3 and
81.8 Mb on chromosome 6 (Fig. 3) for all genotyped and imputed
SNPs. Of 1,833 SNPs in this region, 94 were identiﬁed as pQTLs
and eQTLs for leptin and FAM46A, respectively, assuming an
uncorrected 5% nominal signiﬁcance level. All QTL SNPs
displayed opposite association direction between leptin protein
and FAM46A gene expression, consistent with a regulatory role of
FAM46A on leptin.
To evaluate if FAM46A levels directly inﬂuenced leptin
secretion, we performed knockdown and overexpression studies
in the SGBS human adipocyte cell line. For knockdown
experiments, a speciﬁc siRNA for the FAM46A gene was
designed. Transfection with siRNA resulted in a 70% and 74%
reduction of FAM46A gene expression in the basal and insulin
stimulated state, respectively. FAM46A protein was reduced by
31% and 73% in the basal and insulin-induced state, respectively
(Fig. 4a, b and Supplementary Fig. 13). FAM46A knockdown
had no inﬂuence on leptin gene expression (Fig. 4c) and did
not show any effect on markers of adipocyte differentiation
PPARγ and CEBPα (Supplementary Fig. 14). Conversely,
FAM46A knockdown resulted in a highly signiﬁcant 49% increase
of insulin stimulated leptin secretion from the adipocytes
(p = 0.0002 one-sided t test for leptin increase). Under conditions
without prior insulin stimulation the knockdown still showed a
marginal 19% increase in leptin secretion (p = 0.065 one-sided test
for leptin increase; Fig. 5a). To evaluate whether the effects of the
knockdown of FAM46A were speciﬁc for leptin we tested the
secretion of adiponectin. Secretion of adiponectin was not
affected by the knockdown (Supplementary Fig. 15).
To overexpress FAM46A, SGBS cells were transfected with 0.5
µg of full length FAM46A cDNA. This resulted in a 21-fold
increase of FAM46A expression (Supplementary Fig. 16).
FAM46A overexpression resulted in a signiﬁcant 28% and
24% (p = 0.034 and 0.038, one-sided t test, for both basal and
insulin stimulated states, respectively) reduction of insulin and
non-insulin stimulated leptin release, respectively (Fig. 5b).
Overexpression did not inﬂuence PPARγ or CEBPα gene
expression (Supplementary Fig. 17). Adiponectin release was
not affected by FAM46A overexpression, both in the basal as well
as the insulin stimulated state (Supplementary Fig. 18).
Comparison of pQTLs with known GWAS loci. Locke et al.2
performed the largest GWAS of BMI in 339,224 individuals.
Among all pQTL SNPs identiﬁed in our study, 16 were nominally
(p< 5%) associated with BMI in the published GWAS2 (Sup-
plementary Data 6). Overall, the identiﬁed pQTL SNPs were
signiﬁcantly enriched in SNPs nominally associated with BMI
in Locke et al.2 (permutation test p = 0.009). No LCD pQTL
displayed association with BMI in the published GWAS2.
Extending the comparison to variants in LD with pQTL SNPs did
not extract more BMI association results.
Inversely, pQTL signals from the 97 BMI-associated SNPs
identiﬁed in Locke et al.2 were extracted from the current study.
Information from 62 SNPs was available. Missing SNPs were
replaced by SNPs in LD (r2> 0.8), leading to a total of 83 SNPs
available for analysis. For each protein, pQTL association for
these SNPs was calculated and p values corrected for multiple
testing using the Benjamin–Hochberg method48.
Thirty-one out of 83 GWAS SNPs displayed nominal
association with expression levels of one protein at least at
baseline (Supplementary Data 7). All were identiﬁed as trans-
regulating pQTLs including pQTLs for FTO and CRP. During
LCD, 16 SNPs were identiﬁed as potential pQTLs (Supplementary
Data 8). However, none of the SNPs reached signiﬁcance at the
proteome-wide level at baseline or during LCD.
Discussion
Large-scale pQTL studies looking at different metabolic
states are rare. In the current study we addressed the question of
how genetic variation contributes to protein level differences in
obesity by performing proteome quantitative trait analyses
and comprehensive genotyping in a large cohort of obese
individuals before and after a weight loss intervention. We
showed that one third of 192 proteins associated with BMI at
baseline are regulated by common genetic variants. To our
knowledge, this is the ﬁrst pQTL analysis in obese subjects,
following a dietary intervention. Previous studies focused on
association between baseline protein levels and BMI in the gen-
eral population. About a third of the pQTL signals were in trans,
meaning that these pQTLs harbor potential regulators of the
associated proteins. This number of distant pQTLs correlates well
with recently published pQTL studies in humans28,33 and in
mice13. The pQTL analysis performed in mouse strains
also conﬁrmed that distant (trans-) pQTLs can identify causal
intermediates or distant proteins regulating levels of the pQTL
associated protein13.
Some of our baseline cis-pQTLs are for proteins
already implicated in obesity previously. For example, IL-1RAP
levels have been reported as being lower in obese compared
to normal weight individuals and a genetic association with
protein levels was reported in a candidate gene study49. We
identiﬁed a new pQTL for IL-16 levels. IL-16 is a chemoattractant
and modulator of lymphocyte activation. Inﬁltration of
adipose tissue by lymphocytes and the resulting local inﬂamma-
tion are thought to be involved in promoting insulin resistance.
Indeed, IL-16 levels in plasma were positively correlated
Table 3 Functional annotation of 102 cis and 45 trans-pQTL associated to proteins level at baseline
Function Cis regulation Trans regulation
Count Proportion Corrected p value Count Proportion Corrected p value
3′downstream 0 0 1 1 0.022 1
5′upstream 9 0.088 0.00061 4 0.089 0.057
5′utr 1 0.01 1 1 0.022 0.5
coding 10 0.098 0.00022 1 0.022 1
intergenic 30 0.294 1 16 0.356 1
intronic 51 0.5 1 22 0.489 1
non-coding intronic 1 0.01 0.22 0 0 1
p value from two-tailed Fisher’s exact test for enrichment analysis of pQTL SNPs among regulatory elements were adjusted for multiple testing using Bonferroni correction
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with CRP, a marker for inﬂammatory status (Spearman ρ = 0.17,
p = 1.1 × 10−4).
Our strongest trans-pQTL signal at baseline was for sE-Selec-
tin, previously shown to be associated with obesity. The pQTL
SNPs were located within the ABO gene on chromosome 9 which
also displayed an eQTL signal using DIOGenes transcriptomics
information. sE-Selectin plays a role in cell adhesion in inﬂam-
matory processes. Our ﬁndings conﬁrm that genetically deter-
mined variation of ABO gene expression alter the abundance of
sE-Selectin30, probably mediated through changing glycosylation
of the protein.
Among other strong trans-pQTL signals we would like to
highlight the trans-pQTL for calpastatin on chromosome 10.
Calpastatin is an endogenous calpain inhibitor, involved in
inﬂammatory processes31. This protein has been reported as a
potential activator of adipose-derived stromal stem cells that
have been associated with the occurrence of certain cancers50.
The same study also reported that obesity leads to a dysregulation
of calpastatin. The strongest trans-pQTL SNP for this protein
lies in the carboxypeptidase N subunit 1 (CPN1) gene, a
metalloprotease that regulates other proteins through speciﬁc
cleavage of amino acids from the C terminal. CPN1 has been
shown to be a pleiotropic regulator of inﬂammation51. Expression
for CPN1 was not available in our data. However, a strong
association signal was identiﬁed in our eQTL study for the more
distant gene CWF19L1, predicted to be involved in cell cycle
control.
We also identiﬁed trans-pQTLs that inﬂuence the levels
of several proteins. A locus on chromosome 3 was signiﬁcantly
associated with the levels of PUR8 encoded by the ADSL
gene, involved in uric acid metabolism; ferritin encoded by
FTH1, involved in iron storage and CA1, a carbonic anhydrase.
Recently, Gao et al.52 demonstrated that leptin transcription
was regulated by iron, making serum ferritin levels one of the
best predictors of leptin serum levels under physiological
conditions. Comparison of results from our eQTL analysis for
all genes in the pQTL region identiﬁed TIPARP as the gene
with the strongest association signal. This gene was already
identiﬁed in a genome-wide meta-analysis as a candidate for the
regulation of circulating leptin levels and its expression was
increased in subcutaneous adipose tissue and liver of mice fed
with high-fat diet32.
The functional relationship between these proteins is not
known. However, both uric acid and ferritin (the levels of which
are determined in part by the associated proteins) have been
shown to be markers for non-alcoholic fatty liver disease
(NAFLD) and its progression, a major and frequent complication
in obese individuals53. CA is also a major regulator of uric acid
levels and CA inhibitors are frequently used as diuretics and in
the treatment of gout. It is intriguing that expression levels of the
TIPRAP gene are elevated in the livers of high-fat fed mice. Thus,
one may speculate that the pQTL variant could be involved in the
etiology of NAFLD through the regulation of the levels of these
three proteins.
One of the most interesting and novel ﬁndings of our study is
that an intervention like a low-calorie weight loss, identiﬁed
pQTLs that are not detectable at baseline. All of the pQTLs
detected under the intervention were in trans, providing evidence
that a shift in homeostasis affected protein intermediates that may
be activated by the intervention and regulate the pQTL associated
protein. The example we wish to highlight is the trans-pQTL for
leptin, one of the most studied proteins in obesity. Leptin
levels are associated with BMI and change during weight loss15.
However, surprisingly little is known about the regulation of
leptin secretion. The pQTL on chromosome 6 is located between
two genes, BCKDHB, which codes for a protein implicated in
BCAAs catabolism, and FAM46A, a protein belonging to the
superfamily of nucleotidyltransferase fold proteins. Both proteins
are expressed in adipocytes. Analysis of the pQTL SNPs showed a
consistent cis-eQTL signal for FAM46A using transcriptomics
data from 151 DIOGenes subjects but not for BCKDHB or
any other gene within a 5 Mbase interval around the pQTL.
Thus FAM46A seemed the most likely intermediate for the
leptin pQTL. The exact function of FAM46A is unknown. It
has been associated with the SMAD pathway and TGF-beta
signaling and also with heat shock protein (Hsp70)-mediated
stress response. FAM46A was upregulated during the low-calorie
intervention, which causes a strong metabolic stress response.
None of the two leptin associated pQTL SNPs or any SNPs in
the surrounding region was found associated with leptin in the
Kilpelainen et al.32 meta-analysis. This study used population-
based cohorts and tested association between common genetic
variants and circulating leptin levels at baseline whereas our
pQTL associated with leptin change only during the weight loss
intervention. This may be due to a speciﬁc induction of the
FAM46A gene or protein during weight loss. The reciprocal
relationship between FAM46A and leptin is also apparent in the
shift of gene expression during adipocyte differentiation. Thus,
the external stimulus and drastic change would be necessary to
identify the relationship. We believe that this is a ﬁrst example
that an environmental cue (like a low-calorie diet) that will
induce large changes in gene and protein expression can lead to
the identiﬁcation of pQTL signals not detectable at baseline
homeostasis.
To determine whether FAM46A variation directly inﬂuenced
leptin levels, we used a siRNA approach to knockdown the
FAM46A gene in the human adipocyte cell line SGBS. We
show that the reduction of FAM46A expression results in higher
leptin protein levels secreted from SGBS cells both at baseline
and after insulin stimulation compared with the wildtype,
although the baseline changes do not reach nominal signiﬁcance,
most likely because of the low leptin secretion levels under
non-stimulated conditions. Leptin gene expression remained
unaltered. This indicates that FAM46A has indeed a negative
regulatory effect on leptin and that this regulation happens at the
protein level. It would also indicate that the SNPs affecting
FAM46A gene expression might at least in part be responsible
for the variability in leptin response seen during the LCD
Table 4 Trans-acting SNP association results for three proteins with signiﬁcant pQTL signal during LCD
Protein SNP Chr Position MA MAF Coef SE p value Adjusted p value
Angiotensinogen rs13200531 6 23242826 G 0.07 -0.22 0.036 3.88 × 10−10 1.19 × 10−10
Leptin rs9344031 6 81400749 G 0.10 0.31 0.059 1.48 × 10−7 1.11 × 10−7
Leptin rs481777 6 81578293 G 0.24 0.22 0.042 1.38 × 10−7 5.57 × 10−6
Caspase-10 rs1544241 18 855264 T 0.44 0.09 0.017 1.57 × 10−7 2.36 × 10−7
MAF, pQTL p value (pvalue) and corresponding tested protein are provided
SNP single-nucleotide polymorphism, Chr chromosome, MA minor allele, MAF minor allele frequency, Coef estimated association coefﬁcient, SE standard error
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intervention. Conversely, overexpression of FAM46A resulted in a
signiﬁcant reduction of leptin secretion in line with our
hypothesis. Both knockdown as well as overexpression did not
alter PPARγ and CEBPα levels or adiponectin secretion, indicat-
ing that the changes seen in leptin secretion are not due to effects
of FAM46A on adipocyte differentiation and that the effects seem
to be speciﬁc for leptin.
Of 42 proteins associated both with BMI at baseline and during
LCD, 38 were already investigated in a population-based study
and identiﬁed as correlated to BMI28. Comparison of pQTL
signals with two large independent studies28,33, conducted in the
general population, further supported our pQTL ﬁndings and
highlighted 22 pQTL signals that were common between all three
studies. Both our functional assays and comparison of association
signals with studies of slightly different design, lend support to
our results and stress the importance of our identiﬁed pQTL
signals and their potential role in regulation of proteins like
FAM46A and gustin.
Our study has some limitations. Proteomics information was
available from plasma while eQTL analyses were carried out in
samples from adipose tissue biopsies in a smaller subset of par-
ticipants of the DIOGenes study. This limitation of tissue avail-
ability between omics data did not allow us to perform tissue
speciﬁc pQTL-eQTL comparative analyses like in Chick et al13.
We therefore used a two-step pQTL-mapping strategy combined
with eQTL mapping to limit the multiple testing burden and gain
greater insight in the mechanism underlying the GWAS signal.
This approach enabled us to conﬁrm local transcriptional effects
on cis-pQTL’s in some cases and also to identify the most likely
regulatory transcripts for trans-pQTLs like in the case of
FAM46A. Similarly to eQTL5, effect sizes of cis-acting pQTLs are
expected to be larger than those of trans-acting pQTLs leading to
a higher number of cis-pQTLs as observed at baseline in the
current and previous studies13. Thus, the complete absence of cis-
acting SNP’s during the LCD intervention was an unexpected
result. Extending our pQTL analysis to all proteins including
those not correlated to BMI during LCD identiﬁed 42 proteins.
All of them were regulated by trans-acting genetic variants.
The same observation held true when relaxing the cutoff
for corrected association p values to 0.20 with 175 proteins
identiﬁed associated with trans-acting pQTL SNPs only (n = 233
SNPs with uncorrected p values ranging from 1.6 × 10−10 to
7.7 × 10−7). We believe this to be an important ﬁnding as it
indicates that an intervention, like the low-calorie diet in our
study, may be especially suited to identify causal intermediates of
such distant pQTL signals that are not detectable at baseline
because these intermediates are only activated by the
intervention.
In conclusion, we performed the ﬁrst large-scale pQTL study
in a complex disease reported to date. Using data from a
dietary intervention study in obese patients we identiﬁed multiple
cis-pQTL and trans-pQTL signals associated with BMI at baseline
and after the intervention. Finally we provide evidence for
FAM46A being a negative regulator of leptin in human adipose
tissue.
Methods
Dietary intervention study. This study is part of the Diet, Obesity, and
Genes (DIOGenes) intervention study. A complete description of this dietary
intervention is provided in Larsen et al.14. Brieﬂy, 932 Caucasian overweight or
obese subjects were recruited in clinical centers from eight European countries
(Maastricht, The Netherlands; Copenhagen, Denmark; Cambridge, UK; Heraklion,
Greece; Potsdam, Germany; Pamplona, Spain; Soﬁa, Bulgaria; and Prague, Czech
Republic). Supplementary Fig. 19 displays the ﬂowchart for DIOGenes participants’
selection. Participants followed an initial 8 weeks weight loss intervention on a low-
calorie formula diet (LCD 3300 kJ/day, ca. 800 kcal; Modifast; Nutrition et Santé).
The mean weight loss during LCD was 10.3 kg (interquartile range: 8.7–12.8 kg)14.
Protein measures. Protein expression was measured using a multiplexed aptamer-
based proteomic technology developed by SomaLogic Inc (Boulder, CO). The
SOMAscan proteomic assay has been described in previous publications54,55.
Brieﬂy, this approach uses ﬂuorescently labeled poly-nucleotide aptamers that
recognize speciﬁc protein epitopes, similar to protein antibodies quantiﬁed using
relative ﬂuorescence on microarrays. A set of 1129 proteins was measured and
quantiﬁed directly from plasma samples under fasting conditions before and after
intervention. Therefore, resulting protein measurements were reported in relative
ﬂuorescence units. Outliers were identiﬁed based on interquartile range (IQR;
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IQR =Q3–Q1, where Q3 is the third quartile and Q1 is the ﬁrst quartile of data
distribution). Protein data were available for 530 DIOGenes participants before
and after the intervention. Extreme outliers were set as missing if out of protein
values± 6 IQR. Participants were excluded (n = 18) if more than 5% of proteins
were outside ± 4 standard deviations at baseline or after LCD. Protein data were
log2 transformed for normality for 512 informative DIOGenes participants.
Principal component analysis did not highlight effects of age, gender or center on
protein variation during the intervention. The three ﬁrst components explained up
to 60% of the variance, respectively 49%, 8%, and 3%.
At the time of the analysis, 1,129 proteins were available with the Somalogic
Assay. A revision was published recently by the company removing ﬁve reagents
from future assay results reporting: Alkaline phosphatas, C1s subcomponent,
Desmoglein-2, Reticulon-4, and Tumor necrosis factor receptor superfamily
member 25. Results from these proteins were kept in the current analysis but not
interpreted in the manuscript.
Gene expression. Abdominal subcutaneous adipose tissue samples were
obtained before and after LCD intervention in subjects following an overnight fast
(see Armenise et al.56 for more information on biopsies and RNAseq analyses).
RNA was quantiﬁed with Ribogreen (Life Technologies) and RNA quality deter-
mined using a Bioanalyzer (Agilent Technologies). TruSeq RNA Library Pre-
paration Kit v2 was used to prepare the sequencing libraries from 250 ng total RNA
and quantiﬁed by Picogreen (Life Technologies). Fragment sizes were assessed
using DNA High Sensitivity Reagent kit on a LabChip GX (Perkin Elmer). A v3
paired-end sequencing ﬂow cell (Illumina) was then used to pool and cluster the
libraries at a concentration of 8 pmol. Finally sequencing was performed on a
HiSeq 2000 for 2 × 100 cycles following Illumina’s recommendations. A ﬁrst PCA
was performed on all data for outlier detection based on exclusion of samples with
principal component 1 and 2 out of twice the interquartile range at each time point.
RNAseq data included count information for 54,035 genes. Only subjects with
transcriptomics information at CID1 (baseline) and 2 (after LCD intervention) and
no outliers based on PCA were kept for further analysis.
Count data were ﬁltered and transformed to normality for analysis. Data were
normalized by calculating the reads per kilobase per million mapped reads57
(RPKM) for each gene. RPKM normalized read counts by library size. Expression
matrices were derived from RPKM values at the gene level. Data were log2
transformed with a starting value (prior count = 1, i.e., a starting value used to
offset small counts) that was added to all observed counts to avoid missing values
when computing logarithms on zero counts. More than 15,000 genes with no read
counts at CID1 and 2 and were excluded.
Gene ﬁltering was decided based on more than 50% of participants with more
than one read count to keep a maximum of genes in the analysis (i.e., exclusion of
genes with 0 read counts in more than 50% of the cohort = detected in more than
50% of the cohort). A list of 26,622 genes fulﬁlled the selection criteria.
Genotyping. Before genotyping, a quality check of genomic and ampliﬁed DNA
samples was conducted. Samples were then quantiﬁed and normalized to
approximately 100 ng/ml and 2.0 mg. Genotyping of 748 DIOGenes participants
was performed using an Illumina 660W-Quad SNP chip on the Illumina iScan
Genotyping System (Illumina, San Diego, CA, USA) in accordance with manu-
facturer’s protocols. The integrated mapping information is based on NCBI’s build
37. 498,233 SNPs were genotyped with call rate> 98% and Hardy–Weinberg
equilibrium p> 1.0 × 10−6. Imputation was performed on the Michigan Imputation
Server58 using a European 1000 Genomes set reference panel. Imputation data was
converted to best-guess genotypes (genotype probability threshold 0.8). Imputed
genotypes with an imputation quality score <0.8 and a minor allele frequency< 5%
were discarded. A total of 4,020,654 SNPs were available for analysis in 494
participants with proteomics data and a subset of 151 subjects with gene expression
data before and after intervention. A description of the two cohorts is provided in
Supplementary Table 2.
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Fig. 4 FAM46A gene silencing effect on leptin protein expression in SGBS adipocytes. SGBS cells were transfected with negative control siRNA (siNEG) or
FAM46A-speciﬁc siRNA (siFAM46A) and experiments were performed 48 h after transfection. Gene expression and protein measurements for FAM46A
were conducted at the basal and insulin stimulated states at the same time as leptin expression/secretion analyses at day nine. a Gene silencing of
FAM46A in SGBS adipocytes. Gene expression levels are expressed relative to TBP (TATA Binding Protein) gene expression for FAM46A. Results are given
as the mean± s.d. (standard deviation) for basal or insulin stimulated state (n= 9); b Western blot for FAM46A protein expression in SGBS adipocytes in
wildtype and FAM46A knockdown. FAM46A expression was detected in cell lysate by Western blotting. Protein expression levels are expressed relative to
Actin expression (n= 2). c Effects of FAM46A knockdown on leptin gene expression at basal non-insulin stimulated conditions and after stimulation with
100mM insulin. Gene expression levels are expressed relative to TBP gene expression. Results are given as the mean± s.d. (n= 9). *p< 0.05, **p< 0.01
are provided for statistical signiﬁcance calculated using a Student’s t test
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Proteome-wide association study. LCD-induced change was quantiﬁed by
weight loss expressed as fold change in BMI before (CID1) and after (CID2) LCD
intervention. Protein change between CID1 and CID2 was computed like BMI
change as the log2 fold change between CID2 and CID1. Association between each
protein and BMI was performed using a linear regression adjusted for age, gender,
and center. To identify proteins associated with BMI level in obese participants, a
ﬁrst analysis was performed using data at baseline. Then, we conducted a second
analysis using proteins and BMI level change between CID1 and CID2 in order to
identify proteins associated with weight loss. p values were corrected for multiple
testing using Benjamini–Hochberg standard false discovery rate correction48. A 5%
p value cutoff was used to deﬁne the association as signiﬁcant. Despite a log2
transformation, protein distribution may still have a non-normal distribution,
which may imply non-normal residuals and affect association results. The same
analysis was performed using a rank-based inverse normal transformation
which forces normality of protein distribution based on rank of expression values.
p values from both analyses were compared and did not highlighted differences.
Correlation and network and canonical pathway analysis. Correlation between
proteins was presented in a heatmap. Protein residuals were obtained regressing
corresponding expression on age, center, and gender. Protein residuals pairwise
correlation was quantiﬁed by mean of the Spearman ρ correlation coefﬁcient.
Results were plotted in a symmetric heatmap matrix using R function heatmap.2.
IPA (Ingenuity Systems, Redwood City, CA) was used to create molecular
networks based on protein-coding genes name, expression and p values for each
protein available in our data and integrative information from a large structured
collection of observations with nearly 5 million ﬁndings manually curated from the
biomedical literature or integrated from third-party databases59. Proteins were
clustered into canonical pathways and p values determining an enrichment of
selected proteins in these pathways computed using a Fisher’s exact test as
proposed by IPA. A Benjamini–Hochberg correction for multiple testing was
applied and only pathways that met the p value cutoff p< 0.05 were considered.
Default parameters were used limiting source of data from mammalian studies in
the Ingenuity Knowledge Base. The reference set of genes to consider for test p
value computation was limited to genes coding for proteins available on the
proteomics assay.
QTL mapping. pQTLs were mapped using a linear mixed model (LMM) with
GCTA software60. Sex, age, and center were added to the model as confounding
variables with a random polygenic term modeling genome-wide sample structure
(the genetic background of all patients in the study). To avoid confounding effects
of BMI, pQTL GWAS were performed with and without addition of BMI as
confounding factor. GCTA software was used for LMM computation with the
‘loco’ option that excludes all SNPs belonging to the same chromosome as the SNP
under study avoiding multi-collinearity. For each pQTL analysis, the genomic
inﬂation factor (GIF) was estimated using the estlambda function available in the
GenABEL R package61. At baseline, all but one pQTL analysis (pQTL analysis for
tPA protein which did not provide any signiﬁcant results) displayed GIFs ranged
from 0.99 to 1.07 (Supplementary Fig. 20a) suggesting that population stratiﬁcation
(if any after correction for population genetic structure using GCTA) was limited.
During LCD, GIFs ranged from 0.98 to 1.08 (Supplementary Fig. 20b) leading to
the same conclusion.
Correction for multiple testing was performed using SLIDE62 (Sliding-window
method for Locally Inter-correlated markers with asymptotic Distribution Errors
corrected). SLIDE is based on a multivariate normal distribution to provide an
efﬁcient multiple testing correction which is much faster than the gold standard
permutation test with similar accuracy62 and more tractable when applied to
association between 1,129 proteins and millions of common variants. For each
gene, cis-acting SNPs were located within ±500 Kb of the gene and trans-acting
outside this region. Functional annotation of SNPs was performed using SNPnexus
tool63 based on NCBI RefSeq database. We ﬁrst limited our analysis to SNPs
available on the Illumina chip used for genotyping with a minor allele frequency
(MAF)> 0.05. p values were corrected for multiple testing. SNPs with corrected p
value below 5% were then further investigated enriching signals in targeted regions
with association results from imputed SNPs.
Enrichment analyses of pQTL SNPs among regulatory elements were
performed by two-tailed Fisher’s exact test with the following 2 × 2 table: columns;
pQTL SNPs and non pQTL SNPs, rows; SNPs within and not within the regulatory
element following Takata et al.64. Adjustment for multiple testing was performed
using Bonferroni correction to account for the number of functional type observed
in the study for cis-acting and trans-acting pQTL separately. Enrichment in
regulatory elements could only be performed for baseline pQTL results, the
number of pQTLs upon LCD being too low for any accurate comparison.
Transcriptomics data were available only for a subset of DIOGenes participants.
Because of statistical power limitation, we could not perform a powerful
comparative analysis of eQTL and pQTL results like in Chick et al.13. We decided
to use gene expression information to conﬁrm the regulatory role of genes coding
for proteins with proximal pQTL and identify genes whose expression was likely
involved in regulation of proteins with distant pQTL. For each pQTL association
signal, genes with available expression data located within 2 Mb around the best
associated SNP were identiﬁed as potentially regulated candidate genes. eQTL
association results for the genetic region using all available common genetic
variants were extracted and prioritized based on p values to identify likely regulated
genes as the gene with the strongest eQTL signal.
We used the Genotype-Tissue Expression (GTEx) database to investigate
whether identiﬁed pQTL SNPs were also associated with the expression levels of
contiguous genes in different tissues65. Basically, a SNP was compared with
reported cis-eQTL SNPs from GTEx database. Investigation was limited to SNPs
with cis-eQTL p values below or equal to gene-speciﬁc nominal p value thresholds
as deﬁned by Ardlie et al.65 for adipose tissues (subcutaneous with data available
from 298 samples with donor genotype and visceral omentum tissues with data
available from 185 samples with donor genotype).
pQTL SNPs were evaluated for association with BMI in the Locke et al.2
published large GWAS. To assess the signiﬁcance of the n observed pQTL SNPs,
we used a resampling approach where n SNPs were drawn at random, and we
counted how many of those were associated with BMI (with unadjusted alpha 5%).
By repeating this process 1,000 times we built the null distribution of enrichment
and derived the empirical p value of enrichment computing the proportion of
sampled SNP lists with a higher number of nominal association with BMI in the
GWAS.
SGBS adipocyte cell culture. All the chemicals were from Sigma-Aldrich (Saint
Louis, MO, USA) unless stated otherwise. SGBS adipocytes were obtained from
Prof. Wabitsch at the University of Ulm, Germany. These preadipocyte cells are
derived from adipose tissue of a patient with Simpson–Golabi–Behmel syndrome
(SGBS) and have a unique retained capacity for adipogenic differentiation66. The
SGBS cultures have been repeatedly shown to be mycoplasma-free and negative for
the pathogens HIV, hepatitis B, and EBV. Cells were cultured in basal medium
(DMEM/F12 medium containing 1% PS and 33 µM biotin, 17 µM panthonenate,
and 10% FBS) at 37 °C. To obtain basal serum-free medium (OF), supplement of
FBS was omitted. Differentiation was induced at near conﬂuence by incubation
with OF medium supplemented with 10 µg/ml apo-transferrin, 20 nM human
recombinant insulin, 100 nM hydrocortisone, and 0.2 nM tri-iodothyroxine (T3).
During the ﬁrst 4 days OF medium was additionally supplemented with 25 nM
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Fig. 5 Effects of FAM46A alterations (knockdown and overexpression) on
leptin secretion. a leptin release in the FAM46A knockdown. b leptin release
upon overexpression of FAM46A. Nine-day-old differentiating
preadipocytes were cultured in serum-free basal medium without insulin or
after stimulation with 100 nM insulin for 6 h. Conditioned medium was
removed and the secreted leptin content was measured using a DuoSet
ELISA kit. Accumulated leptin was normalized to total amount of protein
from each well. Results are given as the mean± s.d. (n= 11) with *p< 0.05,
**p< 0.01 for statistical signiﬁcance calculated using a unilateral Student’s t
test for an increased or a decreased leptin release according to a
knockdown or an overexpression of FAM46A, respectively
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dexamethasone, 250 µM 1-methyl-3-isobutylxanthine (IBMX), and 2 µM rosigli-
tazone (Cayman Chemical).
FAM46A gene silencing in differentiating SGBS. Silencing of the FAM46A gene
was achieved by RNA interference through electroporation. Brieﬂy, on day 7 of
differentiation, SGBS cells were detached with trypsin/EDTA and counted. Silencer
Select Negative Control siRNA (siNeg) or gene-speciﬁc siRNA targeting human
FAM46A (Life Technologies, Carlsbad, USA) were delivered into adipocytes at a
concentration of 25 nM per 400,000 cells with the Neon Transfection System
(Invitrogen, Madison, WI, USA) using the following parameters: 1100 V, 20 ms,
1 pulse. After transfection cells were incubated for 48 h in the same media.
FAM46A overexpression. Overexpression of the FAM46A gene was achieved by
cDNA transfection through electroporation. Brieﬂy, on day 7 of differentiation,
SGBS cells were detached with trypsin/EDTA and counted. pCMV6 empty vector
(Control) or FAM46A (NM_017633) full human cDNA ORF Clone (OriGene,
Rockville, MD, USA) were delivered into adipocytes at a concentration of 0.5 µg
per 400,000 cells with the Neon Transfection System (Invitrogen, Madison, WI,
USA) using the following parameters: 1100 V, 20 ms, 1 pulse. After transfection
cells were incubated for 48hr in the same media.
Gene expression measurements for FAM46A and leptin and PPARγ. Total
RNA from SGBS adipocytes was isolated using the Rneasy Plus Mini kit (Qiagen)
at day 9. After assessing quantity and quality with a Nano-Drop, 0.5 µg total RNA
was reverse transcribed using the High Capacity cDNA Reverse Transcription kit
(Applied Biosystems, Foster City, CA, USA) according to manufacturer’s
instructions.
Expression levels of mRNA were determined using a SYBR Green kit
LightCycler 1536 DNA Green Master kit using the LightCycler Instrument (Roche,
Basel, Switzerland). Oligo sequences were designed using the Biology Workbench
website67. Primers for human sequences were obtained from Life Technologies
Europe. FAM46A, Leptin, CEBPα, and PPARγ mRNA levels were normalized
against TATA box-binding protein (TBP). Primers used as listed in Supplementary
Table 3.
Protein quantiﬁcation. At day nine of differentiation SGBS cells were homo-
genized in ice cold M-PER Mammalian Protein Extraction Reagent (#78501,
Thermo Fisher Scientiﬁc, Waltham, MA, USA) supplemented with 250 mM
Sucrose, 1 mM EDTA, 1% NP-40 substitute and complete protease inhibitor
cocktail (Roche GmbH, Mannheim, Germany). After incubation on ice for 10 min
and centrifugation at 10,000 × g for 10 min at 4 °C, the middle phase was removed
and proteins were quantiﬁed using the Bio-Rad DC Protein Assay Kit. SDS-PAGE
followed by Western blotting was performed using antibodies against FAM46A
(1:1000 dilution, PA5-23898, Thermo Fisher Scientiﬁc, Waltham, MA, USA) or
HSL (1:2000 dilution, #4107, Cell Signalling Technology, Danvers, MA, USA)
following manufacturer’s standard protocol and ß-Actin (1:4000 dilution, #3700,
Cell Signalling Technology, Danvers, MA, USA) was used for normalization.
Species appropriate secondary antibodies conjugated to horseradish peroxidase
(1:10,000 dilution, anti-mouse 711-035-152 or anti rabbit 715-035-150, Jackson
ImmunoResearch Laboratories, Inc, West Grove, PA, USA) were used and proteins
visualized and quantiﬁed by enhanced chemiluminescence using the Bio-Rad GS-
900 calibrated Densitometer.
Leptin and adiponectin secretion. Leptin and adiponectin concentrations were
measured at day 9 in fully differentiated SGBS cells. Cells were washed two times
with serum-free Basal medium and left untreated or treated with 100 nM insulin.
After 6 h of incubation, aliquots of the medium were removed and frozen at −20 °C
for leptin or adiponectin measurements respectively.
Leptin and adiponectin secretion were measured using the human leptin or
adiponectin DuoSet ELISA Development kits (R&D Systems, Inc., Minneapolis,
MN, USA, sensitivity: 0.031 ng/ml for leptin and 0.062 ng/ml for adiponectin
respectively). The assays were conducted in 96-well microplates and read out on a
SpectraMax i3 spectrophotometer (Molecular Devices, LLC, Sunnyvale, CA, USA).
The absorbance value was measured at 450 nm and normalized to the protein
concentration measured by the Bio-Rad DC Protein Assay.
Software. General statistical analysis was performed using R statistical environ-
ment version 3.3.1. We used LocusZoom software for plotting regional association
plots and LD with lead SNP using the 1000 genome CEU population data (hg19/
1000 Genomes Mar 2012 EUR).
URLs. Biology Workbench http://workbench.sdsc.edu;
GCTA, http://cnsgenomics.com/software/gcta/;
https://imputationserver.sph.umich.edu/index.html#!pages/home;
GTOOL, http://www.well.ox.ac.uk/~cfreeman/software/gwas/gtool.html;
GTEx database, http://www.gtexportal.org/home/;
IPA, http://www.ingenuity.com/;
Michigan Imputation Server, https://imputationserver.sph.umich.edu/;
LocusZoom, http://locuszoom.org/
Data availability. Gene expression data are available from the Gene Expression
Omnibus under accession GSE95640. Any additional data (beyond those included
in the main text and Supplementary Information) that support the ﬁndings of this
study are available upon reasonable request by contacting the corresponding
author at jerome.carayol@rd.nestle.com.
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